Loading…
Production of exopolysaccharides from novel marine bacteria and anticancer activity against hepatocellular carcinoma cells (HepG2)
Background The aim of the current study based on the production and characterization of exopolysaccharides (EPSs) isolated from marine sediment of the Mediterranean and Red Seas is to study its cytotoxic activity against HepG2 cells. Results Eleven isolates have the ability to produce EPSs and also...
Saved in:
Published in: | Bulletin of the National Research Centre 2018-12, Vol.42 (1), p.1-9, Article 30 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background
The aim of the current study based on the production and characterization of exopolysaccharides (EPSs) isolated from marine sediment of the Mediterranean and Red Seas is to study its cytotoxic activity against HepG2 cells.
Results
Eleven isolates have the ability to produce EPSs and also decreased the viability of HepG2 cell line in different manners. The five most promising isolates that produce high yield of EPSs and high cytotoxicity were identified by 16S RNA as
Brevundimonas subvibrioides
MSA1,
Bacillus thuringiensis
E4,
Bacillus amyloliquefaciens
MGA2,
Pseudomonas fluorescens
SGA3, and
Advenella Kashmirensis
NRC-7. The chemical composition of the following EPSs (M1, M3, M6, M15, M19, E2, E4, E10, S5, S7, and S11) demonstrates that they are acidic sulfated heteropolysaccharides with different relative ratios of monosugars of glucose, mannose, galactose, glucouronic acid, and mannouronic acid. The average molecular weights from 1.94 × 10
4
to 7.95 × 10
5
g/mol and the number average molecular weight from 1.51 × 10
4
to 7.53 × 10
5
g/mol. FTIR spectrum of the five EPSs indicated the presence of sulfate and carboxylic groups in different percentages.
Conclusions
The EPSs produced from marine bacteria are very promising for treating the HepG2 cells. |
---|---|
ISSN: | 2522-8307 2522-8307 |
DOI: | 10.1186/s42269-018-0032-3 |